Presentation

An original research organization to defeat diabetes

Created in 1991, managed by Pr Michel Pinget, Emeritus Professor at Strasbourg University and subject expert,

the Centre européen d’étude du Diabète (CeeD or European Diabetes Study Center) is today:

recognized as a public benefit organization

accredited by the French Minister of Higher Education and Research and Strasbourg University

certified ISO 9001 : 2015

CeeD’s teams are implementing a global strategy
to fight against diabetes with:

Lab research

Its laboratory team is working on several projects around “Crosstalk Communications Between Islets Cells and Insulin Target Tissue” as the Hidden Face of Iceberg.

>

Tech transfer

From bench to bedside with tech transfert through start-up inceptions.

>

Vaincre le diabète

Its initiative “Vaincre le diabète” (meaning “defeat diabetes”), a campaign dedicated to a large audience in order to increase public awareness and information on diabetes realities, screening and prevention.

>

Message from

the founding president and the lab director


" Data confirmed that despite everyone’s effort, the epidemic is getting worse. This growth can be observed by the increase of persons affected, in particular with an important growth of children with type 1 diabetes and people with type 2 diabetes : including children and teenagers, as well as on the number of people ignoring that they are sick. The consequence is an inevitable rise of financial expenditures. These numbers are alarming since no population seems to be spared. 


We both have made this fight against diabetes our lifelong battle, way before our first meeting in 2015. And since then, we tried together to set up and develop innovative solutions that could help prevent the disease. 


Together, as a clinician and a researcher, our respective job and personal journey allowed us to understand the importance and the necessity to develop a laboratory on a translational vision centered on diabetes gathering all aspects of research to a clinical goal: 

#1 - Improve pancreatic islet transplantation and make it more accessible to as many people as possible

• preserve and condition the donor’s islets

• protect the recipient’s islets

• opening of a human pancreatic islet isolation unit for clinical purposes

#2 - Develop new innovative therapies to prevent or reverse diabetes.


Meanwhile, with our initiative “Vaincre le diabète”, we would provide prevention and screening programs to the general public.


That is why we pursure with CeeD’s teams to meet challenges that diabetes never stops launching us. Increasing public awareness about this pathology, making the patients everyday life easier, to fight the disease with one goal: defeat diabetes! "



PR MICHEL PINGET

Founding President

Diabetologist

Emeritus Professor at Strasbourg University


DR KARIM BOUZAKRI

Laboratory Director

Privat-docent

Message from

the founding president and the lab director


" Data confirmed that despite everyone’s effort, the epidemic is getting worse. This growth can be observed by the increase of persons affected, in particular with an important growth of children with type 1 diabetes and people with type 2 diabetes : including children and teenagers, as well as on the number of people ignoring that they are sick. The consequence is an inevitable rise of financial expenditures. These numbers are alarming since no population seems to be spared. 


We both have made this fight against diabetes our lifelong battle, way before our first meeting in 2015. And since then, we tried together to set up and develop innovative solutions that could help prevent the disease. 


Together, as a clinician and a researcher, our respective job and personal journey allowed us to understand the importance and the necessity to develop a laboratory on a translational vision centered on diabetes gathering all aspects of research to a clinical goal: 

#1 - Improve pancreatic islet transplantation and make it more accessible to as many people as possible

• preserve and condition the donor’s islets

• protect the recipient’s islets

• opening of a human pancreatic islet isolation unit for clinical purposes

#2 - Develop new innovative therapies to prevent or reverse diabetes.


Meanwhile, with our initiative “Vaincre le diabète”, we would provide prevention and screening programs to the general public.


That is why we pursure with CeeD’s teams to meet challenges that diabetes never stops launching us. Increasing public awareness about this pathology, making the patients everyday life easier, to fight the disease with one goal: defeat diabetes! "



PR MICHEL PINGET

Founding President

Diabetologist

Emeritus Professor at Strasbourg University


DR KARIM BOUZAKRI

Laboratory Director

Privat-docent

#1 - Improve pancreatic islet transplantation and make it more accessible to as many people as possible

• preserve and condition the donor’s islets

• protect the recipient’s islets

• opening of a human pancreatic islet isolation unit for clinical purposes

#2 - Develop new innovative therapies to prevent or reverse diabetes.


Meanwhile, with our initiative “Vaincre le diabète”, we would provide prevention and screening programs to the general public.


That is why we pursure with CeeD’s teams to meet challenges that diabetes never stops launching us. Increasing public awareness about this pathology, making the patients everyday life easier, to fight the disease with one goal: defeat diabetes! "


PR MICHEL PINGET

Founding President

Diabetologist

Emeritus Professor at Strasbourg University


DR KARIM BOUZAKRI

Laboratory Director

Privat-docent

CeeD’s history

Great European "premieres" in diabetology initiated by Pr Michel Pinget


Even before it was created, CeeD was associated to the great European “premieres” in diabetology initiated by Pr Michel Pinget, its founding president.


  • 1979: first insulin pump for a patient in Strasbourg
  • 1989: first series of 9 insulin pump implants in Strasbourg
  • 1999: first pancreatic islets transplant in Strasbourg

Our first supports


The creation of CeeD and more specifically the construction of its research laboratory building within Hautepierre Hospital site (Strasbourg University Hospital) was possible thanks to the support of:

  • local authorities such as the Regional Council of Alsace, the General Council of Bas-Rhin, the General Council of Haut-Rhin, the City of Strasbourg
  • regional scientific and university authorities (Strasbourg University Hospital, Strasbourg University, INSERM which is a public scientific and technological institute)
  • health institutions such as ARPEGE group
  • volunteers, who invested themselves in our non-profit initiative “Vaincre le diabete”.

CeeD’s milestones

1991

In response to the World Health Organization’s concerns about the rise of diabetes in the world, Professor Michel Pinget created a unique research and innovation structure: Centre européen d’étude du Diabète (CeeD).

1996

CeeD becomes a WHO’s collaborator for diabetes around the world.

2001

Recognition of the Public Utility Mission by prefectural decree on August 13th.

2002

Creation of ASDIA, a home healthcare company (insulin pumps), whose entire profits were then donated to research.

2005

Publication in "The Lancet" journal of the first epidemiological study on diabetes prevalence in Cambodia 

Inauguration of the new CeeD’s building where its research laboratory is still located. 

2013

Accredited by the Minister of Higher Education and Research and the Strasbourg University as one of its certified research center “Diabète et thérapeutique” (DIATHEC) - UR 7294

2014

Sale of ASDIA. All benefits were donated to CeeD’s research.

2016

Arrival of Dr Karim Bouzakri as laboratory director. Under his leadership, research projects focus on crosstalk between skeletal muscles and pancreas. 

Organisation of the 1st Scientific and Medical Congress, EuroDia Meeting.

2017

The lab received the European “Marie Sklodowska-Curie” grant. It will allow the coming of a high level researcher and thus accelerate CeeD research work on the understanding of diabetes’ cellular mechanisms and more particularly on the link between physical exercise and diabetes.

Organisation of the second Scientific and Medical Congress, EuroDia Meeting.

2018

Creation of CEED Formation, training center fors healthcare professionnals, which benefits are donated to the CeeD’s research.

2019

Organisation of the third Scientific and Medical Congress, EuroDia Meeting.

2020

Creation of Ilonov, a start-up dedicated to the development of new first-in-class biotherapies targeting diabetes prevention and treatment, with muscle products.

Creation of Institut Prévention Santé Diabète Grand Est (IPSDE), the first health centre in France dedicated to prevention and outpatient support for people with diabetes and metabolic diseases (created in partnership with LNA Santé, a recognized expert in health centre modelling).

2021

Opening of a Maison Sport et Santé to promote physical activity, with the French Minister of Sport and Olympic and Paralympic Games and Minister of Solidarity and Health

Share by: